English, PDF, 150kb
Health at a Glance provides the latest comparable data and trends on population health and health system performance. This Country Note shows how Portugal compares to other OECD countries across indicators in the report.
English, PDF, 223kb
Antimicrobial resistance (AMR) – the ability of microbes to resist antimicrobials - remains an alarming global health threat that jeopardises the effectiveness of many 20th century public health advances. In recent years, Portugal made important strides in tackling AMR. Yet, more progress is needed.
Portuguese, PDF, 263kb
A resistência antimicrobiana (RAM) - a capacidade de micróbios resistirem aos agentes antimicrobianos - continua a ser uma ameaça alarmante para a saúde mundial que põe em causa a eficácia de muitos dos avanços do século XX no domínio da saúde pública. Nos últimos anos, Portugal registou avanços importantes na luta contra a RAM. No entanto, são necessários mais progressos.
Portugal’s recovery has slowed in the face of high energy and living costs, as well as global uncertainty. Decisive policy action and structural reforms are needed to shore up public finances, uphold living standards and ensure that growth remains on a sustainable and resilient path, according to a new OECD report.
The tax wedge for the average single worker in Portugal remained unchanged at 41.9% in 2021 and 2022. The OECD average tax wedge in 2022 was 34.6% (2021, 34.6%).
The OECD’s annual Revenue Statistics report found that the tax-to-GDP ratio in Portugal increased by 0.5 percentage points from 35.3% in 2020 to 35.8% in 2021. Between 2020 and 2021, the OECD average increased from 33.6% to 34.1%.
Since the OECD Anti-Bribery Convention entered into force over 20 years ago, Portugal has not had a single foreign bribery conviction. Detection remains low and Portuguese authorities prematurely closed foreign bribery cases without investigating relevant allegations thoroughly and proactively, with the number of cases terminated having increased significantly compared to Phase 3.